Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00514228
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
DRUG:
sunitinib malate
Sponsor
Swiss Cancer Institute